S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Catalyst Pharmaceutical Partners Initiates Phase 1(b) Safety and Tolerance Study for CPP-115|
|Catalyst Pharmaceutical Partners to Present at Rodman & Renshaw's 16th Annual Global Investment Conference|
|Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development|
|Catalyst Pharmaceuticals Announces Third Quarter 2014 Financial Results|
|UPDATE: Ford falls on Europe woes; Cintas, Synnex up on earnings (2014/9/29)|
|UPDATE: Ford slips on Europe woes, Cintas, Synnex up on earnings|
|Catalyst Pharmaceuticals Announces Positive Top-Line Phase 3 Data From Pivotal Firdapse Clinical Trial in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS)|
|Catalyst Pharmaceuticals to Present at 13th Annual BIO Investor Forum|
|Catalyst Pharmaceuticals to Present Top-Line Safety and Efficacy Results From Phase 3 Firdapse Trial at 139th Annual Meeting of the American Neurological Association|
|Catalyst Pharmaceuticals to Present Firdapse Phase 3 Trial Results at the 61st Annual Meeting of the American Association of Neuromuscular and Electrodiagnostic Medicine|
Click above to view more mutual fund data and stats for cprx - Catalyst Pharmaceutical Partners Inc.